ITFE-CKKER: NEW THERAPEUTIC APPROACH TO THE MUSCULAR DYSTROPHY OF BECKER (DMB) (Q2041423): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 50.00000015450459 percent) |
(Changed an Item) |
||||||
| Property / co-financing rate | |||||||
50.0 percent
| |||||||
| Property / co-financing rate: 50.0 percent / rank | |||||||
Normal rank | |||||||
Revision as of 04:44, 20 March 2020
Project in Italy financed by DG Regio
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ITFE-CKKER: NEW THERAPEUTIC APPROACH TO THE MUSCULAR DYSTROPHY OF BECKER (DMB) |
Project in Italy financed by DG Regio |
Statements
1,618,074.93 Euro
0 references
3,236,149.85 Euro
0 references
50.0 percent
0 references
29 September 2016
0 references
1 November 2019
0 references
ITALFARMACO S.P.A.
0 references
FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO
0 references
OPIS S.R.L.
0 references
45°33'21.82"N, 9°12'50.44"E
0 references
LA DISTROFIA MUSCOLARE DI BECKER (DMB) UNA PATOLOGIA NEUROMUSCOLARE APPARTENENTE AL GRUPPO DELLE DISTROFINOPATIE, DI CUI LA DISTROFIA MUSCOLARE DI DUCHENNE (DMD) RAPPRESENTA LA FORMA PI GRAVE. LE DISTROFINOPATIE SONO CAUSATE DA MUTAZIONI A CARICO DEL GENE DELLA DISTROFINA, UNA PROTEINA FONDAMENTALE PER LA STABILIZZAZIONE DEL CITOSCHELETRO NELLE FIBRE MUSCOLARI SCHELETRICHE E CARDIACHE. LA DMB UNA MALATTIA RARA, DIAGNOSTICATA TRA I 10 E 30 ANNI DI ET, CHE COLPISCE I MASCHI, CON INCIDENZA D (Italian)
0 references
Identifiers
E76D17000080009
0 references